Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
Journal of Internal Medicine2013Vol. 275(4), pp. 398–408
Citations Over TimeTop 1% of 2013 papers
Lamiae Grimaldi‐Bensouda, Didier Guillemot, Bertrand Godeau, Jacques Bénichou, Christine Lebrun‐Frénay, Caroline Papeix, Pierre Labauge, Patrick Berquin, Alfred Penfornis, P.‐Y. Benhamou, Marc Nicolino, Albane Simon, Jean‐François Viallard, N. Costedoat‐Chalumeau, Marie-France Courcoux, Corinne Pondarré, Pascal Hilliquin, Emmanuel Chatelus, Violaine Foltz, Séverine Guillaume, M Rossignol, Lucien Abenhaim, the PGRx‐AID Study Group
Abstract
No evidence of an increase in the risk of the studied ADs was observable following vaccination with Gardasil within the time periods studied. There was insufficient statistical power to allow conclusions to be drawn regarding individual ADs.
Related Papers
- → FDA approves Gardasil 9 for more types of HPV(2015)46 cited
- → Merck'sOne LessCampaign: Using Risk Message Frames to Promote the Use of Gardasil® in HPV Prevention(2011)18 cited
- → Gardasil: A false sense of immunity?(2010)2 cited
- A Case Study of the Development and Promotion of the Gardasil vaccine(2009)
- One Less Risk, Or One Less Girl? Situating Gardasil and Cervical Cancer Risk in the Context of Risk-Reduction Medicine(2014)